In Vivo Metabolite Profiling of DMU-212 in ApcMin/+ Mice Using UHPLC-Q/Orbitrap/LTQ MS
Molecules · 2023
DOI: 10.3390/molecules28093828 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Jing Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Metabolomics Laboratory, Department of Pharmaceutical …. Hauptthemen laut MEDLINE: Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Key Projects of the National Natural Science Foundation of China, the Heilongjiang Province General Undergraduate Colleges and Universities Young Innovative Talents Training Plan, Key Projects of the National Natural Science Foundation of China.
Abstract (Originalsprache)
3,4,5,4’-Trans-tetramethoxystilbene (Synonyms: DMU-212) is a resveratrol analogue with stronger antiproliferative activity and more bioavailability. However, the metabolite characterization of this component remains insufficient. An efficient strategy was proposed for the comprehensive in vivo metabolite profiling of DMU-212 after oral administration in ApcMin/+ mice based on the effectiveness of the medicine. Ultra-high performance liquid chromatography-quadrupole/orbitrap/linear ion trap mass spectrometry (UHPLC-Q/Orbitrap/LTQ MS) in the AcquireXTM intelligent data acquisition mode, combining the exact mass and structural information, was established for the profiling and identification of the metabolites of DMU-212 in vivo, and the possible metabolic pathways were subsequently proposed after the oral dose of 240mg/kg for 3 weeks in the colorectal adenoma (CRA) spontaneous model ApcMin/+ mice. A total of 63 metabolites of DMU-212 were tentatively identified, including 48, 48, 34 and 28 metabolites in the ApcMin/+ mice’s intestinal contents, liver, serum, and colorectal tissues, respectively. The metabolic pathways, including demethylation, oxidation, desaturation, methylation, acetylation, glucuronide and cysteine conjugation were involved in the metabolism. Additionally, further verification of the representative active metabolites was employed using molecular docking analysis. This study provides important information for the further investigation of the active constituents of DMU-212 and its action mechanisms for CRA prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Metabolomics Laboratory, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Heping Road 24,…
- State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau 999078, China.
- State Key Laboratory of Dampness Syndrome, The Second Affiliated Hospital Guangzhou University of Chinese Medicine, Dade Road 111, Guangzhou 510006, China.
Förderung
- the Key Projects of the National Natural Science Foundation of China
- the Heilongjiang Province General Undergraduate Colleges and Universities Young Innovative Talents Training Plan
- Key Projects of the National Natural Science Foundation of China
- Heilongjiang Province General Undergraduate Colleges and Universities Young Innovative Talents Training Plan
Zitieren
APA
Li, J., Li, X., Zhou, X., Yang, L., Sun, H., Kong, L., Yan, G., Han, Y., & Wang, X. (2023). In Vivo Metabolite Profiling of DMU-212 in ApcMin/+ Mice Using UHPLC-Q/Orbitrap/LTQ MS. Molecules. https://doi.org/10.3390/molecules28093828
Vancouver
Li J, Li X, Zhou X, Yang L, Sun H, Kong L, et al. In Vivo Metabolite Profiling of DMU-212 in ApcMin/+ Mice Using UHPLC-Q/Orbitrap/LTQ MS. Molecules. 2023. doi:10.3390/molecules28093828
BibTeX
@article{Li2023,
author = {Li, Jing and Li, Xinghua and Zhou, Xiaohang and Yang, Le and Sun, Hui and Kong, Ling and Yan, Guangli and Han, Ying and Wang, Xijun},
title = {In Vivo Metabolite Profiling of DMU-212 in ApcMin/+ Mice Using UHPLC-Q/Orbitrap/LTQ MS},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28093828}
}
EUVIMED